TWI433686B - Far-infrared substrate for whitening skin - Google Patents

Description

Far infrared ray substrate for whitening

This case refers to a far-infrared substrate, and in particular to a far-infrared substrate for whitening.

The melanin of the human body is formed by the oxidation of tyrosine in the melanocytes of the skin by tyrosinase, so the white-skinned person is the function of tyrosinase, which is suppressed and appears white and black. People are the result of the strong tyrosinase action. Generally, commercially available whitening products use chemical methods to reduce the formation of melanin, for example, using plant-derived arbutin, but the use of chemical methods to whiten often has problems of poor absorption of active ingredients, and even more susceptible to skin irritation and discomfort. The effect, and the effect of whitening is greatly reduced.

Far-infrared rays are electromagnetic waves with a wavelength of 3-1000 micrometers. The far-infrared rays with wavelengths between 3 and 14 micrometers have a promoting effect on the growth of animals and plants, so scientists call them life rays. Far-infrared rays not only do not stimulate the human body, but can increase the energy of the human body. Its characteristics are that it can penetrate into the internal tissues of the human body, promote the resonance of water molecules in the cells of the human body, impart vitality to the cells, accelerate blood circulation, activate metabolism, and promote tissue regeneration. The ability to activate the immune system, etc., has been medically proven to have therapeutic effects on a variety of human diseases.

As a result of the job, the inventor, in view of the lack of the prior art, has carefully tested and researched the spirit of perseverance, and finally invented a composition and substrate that utilizes the far-infrared function to achieve whitening purposes. A brief description.

The present invention provides a physical whitening method for solving the malabsorption and allergic defects such as the use of chemical methods to whiten in the prior art.

The purpose of the present invention is to provide a far-infrared ray cream comprising a far-infrared emitting substance, the main component of which is an oxidized mineral, wherein the oxidized mineral comprises 60-95% of alumina.

According to the above concept, the far-infrared cream further contains other active substances, adjuvants and additives.

According to the above concept, the far-infrared cream is a cosmetic product.

According to the above concept, wherein the cosmetic preparation further comprises at least one selected from the group consisting of oils, fats, waxes, hydrocarbons, fatty acids, sterols, hormones, vitamins, fatty acid esters, humectants, surfactants, pigments, viscosity improvers, and Cosmetic raw materials for films, UV absorbers, antifungals, anti-inflammatory agents, antiperspirants, preservatives and fragrances.

According to the above concept, the far-infrared cream is a medical product.

According to the above concept, the far infrared ray cream is an industrial product.

According to the above concept, the industrial product is selected from the group consisting of paints, coatings, lubricants, films, gels, paper sizing agents, latexes, building or building materials, inks, dyes, waxes and glazing agents.

According to the above concept, the far-infrared rays released by the far-infrared emitting material have an emissivity of 0.9 or more at a wavelength of 4 to 16 μm.

According to the above concept, the oxidized mineral further contains 1-20% of iron oxide.

According to the above concept, the oxidized mineral further contains 1-10% of magnesium oxide.

According to the above concept, the oxidized mineral further comprises 1-30% of calcium carbonate.

Another object of the present invention is to provide a far infrared ray substrate comprising a substrate and a far infrared ray releasing substance mixed in the substrate and having a composition comprising 60 to 95% of alumina.

According to the above concept, the substrate is selected from at least one of a metal, a glass, a ceramic, and a polymer material.

According to the above concept, the component of the far-infrared emitting substance further contains 1-20% of iron oxide.

According to the above concept, the component of the far-infrared emitting substance further contains 1-10% of magnesium oxide.

According to the above concept, the component of the far-infrared emitting substance further contains 1 to 30% of calcium carbonate.

According to the above concept, the far-infrared rays released by the far-infrared emitting substance have an emissivity of 0.9 or more at a wavelength of 4 to 16 μm.

According to the above concept, the component of the far-infrared emitting substance contains at least one of alumina, titania, titanium boride, magnesium oxide, cerium oxide, iron oxide, zinc hydroxide, zinc oxide, and carbide.

According to the above concept, the far-infrared emitting substance is structurally selected from at least one of a block, a granule, a powder, and a film.

Another object of the present invention is to provide a composition for whitening, which comprises a far-infrared emitting substance, the main component of which is an oxidized mineral, and the composition reaches the far-infrared rays released by the far-infrared emitting substance. The purpose of whitening.

According to the above concept, other active substances, adjuvants and additives are further included.

According to the above concept, the composition is at least one of an emulsion, a cream, a gel, a solution, a colloidal dispersion, a suspension, an ointment, a lotion, a cream, a foam, a foamed latex, and a gel.

According to the above concept, the composition is a cosmetic composition.

According to the above concept, wherein the cosmetic composition further comprises at least one selected from the group consisting of oils, fats, waxes, hydrocarbons, fatty acids, sterols, hormones, vitamins, fatty acid esters, humectants, surfactants, pigments, viscosity improvers, Cosmetic raw materials for film formers, UV absorbers, antifungals, anti-inflammatory agents, antiperspirants, preservatives and fragrances.

According to the above concept, wherein the composition is a pharmaceutical composition.

According to the above concept, wherein the pharmaceutical composition further comprises a pharmaceutically acceptable carrier.

According to the above concept, the far-infrared rays released by the far-infrared emitting material have an emissivity of 0.9 or more at a wavelength of 4 to 16 μm.

According to the above concept, wherein the oxidized mineral comprises alumina.

According to the above concept, wherein the oxidized mineral comprises 60-95% alumina.

According to the above concept, wherein the oxidized mineral contains 1-20% of iron oxide.

According to the above concept, wherein the oxidized mineral contains 1-10% of magnesium oxide.

According to the above concept, wherein the oxidized mineral comprises 1-30% of calcium carbonate.

The case can be further explained by the following detailed explanation:

The invention will be further described in detail by the following preferred embodiments and the accompanying drawings.

First embodiment

The present invention provides a far-infrared ray cream which incorporates a far-infrared ray releasing substance into a cosmetic cream in different proportions. A preferred ratio is that the cosmetic cream contains 1 to 20% of a far-infrared ray releasing substance. The cosmetic cream comprises oil, fat, wax, hydrocarbon, fatty acid, sterol, hormone, vitamin, fatty acid ester, wetting agent, surfactant, pigment, viscosity improver, film former, ultraviolet absorber, antifungal Cosmetic ingredients such as anti-inflammatory agents, antiperspirants, preservatives or fragrances. In order to make the cosmetic cream more effective at the same time, it may also contain other active substances, adjuvants and additives. The far-infrared cream of this embodiment is confirmed by standard normative experiments to not cause skin allergic reaction, so the far-infrared cream should be used as a skin for external whitening.

The raw material of the far-infrared emitting material in the present embodiment is a high-efficiency far-infrared ceramic powder jointly developed by the Instrument Technology Research Center and the Taipei Medical University, and its biological effects have been confirmed by a number of experiments to have a considerable degree of effect. The composition consists of several natural mineral components, which may comprise 60-95% alumina, 1-20% iron oxide, 1-10% magnesium oxide and 1-30% calcium carbonate. Other ingredients may still contain titanium dioxide, titanium boride or more natural mineral components such as cerium oxide, zinc hydroxide, zinc oxide and carbides. The black body is used as a reference and measured by a far-infrared spectrometer. The far-infrared emitting material has an average release rate of 0.98 or more in the range of 6 to 14 micrometers in the wavelength range of the living light. And the sterilization rate is tested according to the American AATCC100 standard method, and the released far infrared rays have an antibacterial effect of 99.9% or more for both Staphylococcus aureus and Escherichia coli.

The far-infrared cream in the present embodiment is a cosmetic product, which provides a coating for external application of the skin to whiten the skin, enhance blood circulation, promote metabolism, improve personal physique, and thereby achieve health care. However, the type thereof is not limited thereto, and it may also be a medical product or an industrial product.

If the far infrared ray cream provided by the invention is an industrial product, it can be used as paint, paint, lubricant, film, gel, paper sizing agent, latex, building or road building material, ink, dye, wax and light Agents, etc. As long as it is in the environment of these industrial products, the influence of the far-infrared rays on the front side of the human body can be obtained, and the wide range of applications and influences of the far-infrared cream can be seen.

Second embodiment

Please refer to the first drawing, which is a schematic view of a second preferred embodiment of the far infrared ray substrate of the present invention. As illustrated, the far infrared ray substrate of the present invention comprises a substrate 20 and a far infrared ray releasing substance 10 mixed in the substrate. The substrate 20 is selected from at least one of metal, glass, ceramic, and polymer materials. The far-infrared emitting substance 10 is structurally selected from at least one of a block, a granule, a powder, and a film. Other properties such as composition and efficacy of the far-infrared emitting substance 10 are the same as those in the first embodiment, and thus will not be described again.

The far-infrared substrate can be applied in a wide range of applications, especially for the purpose of whitening, the far-infrared substrate can be made into various instruments, medical supplies, building materials, vehicles or textiles in daily life, so as to be whitened anytime and anywhere. Convenience.

Third embodiment

A third embodiment of the present invention is a composition for whitening, which comprises a far-infrared emitting substance, and other properties such as composition and efficacy of the far-infrared emitting substance are the same as those in the first embodiment, and thus will not be described again. The composition achieves the purpose of whitening through the far infrared rays released by the far-infrared emitting substance. The whitening composition of this embodiment may contain other active substances, adjuvants and additives to achieve more efficacy. The whitening composition of this embodiment can be presented in various forms such as emulsions, creams, gels, solutions, colloidal dispersions, suspensions, ointments, lotions, creams, foams, foamed latex or gels and the like. If the composition is added to a cosmetic, the cosmetic may comprise oil, fat, wax, hydrocarbon, fatty acid, sterol, hormone, vitamin, fatty acid ester, humectant, surfactant, pigment, viscosity improver, film formation. Cosmetics such as agents, UV absorbers, antifungals, anti-inflammatory agents, antiperspirants, preservatives and fragrances. If the composition is for pharmaceutical use, the pharmaceutical composition may comprise a pharmaceutically acceptable carrier, excipient or diluent which is used in various ways for whitening purposes.

Please refer to the second figure (a)(b), which discloses a histogram of the effect of the far infrared ray releasing substance provided by the present invention on the melanin content in B16F10 cells. In this test, B16F10 melanoma cells were used as test materials, and a cell culture plate containing 10 ⁴ B16F10 melanoma cells per plate was cultured at 37 ° C for 24 hours. Then, the cell culture plates were placed on a 100 gram far-infrared emitting material (experimental group) and 100 gram of milk powder (control group), so that the cells were not in direct contact with the far-infrared emitting material, and the cells were collected after 24 and 48 hours. After lysing the cells, the absorbance at a wavelength of 475 nm was measured by a spectrophotometer as a representative of the melanin content in the cells. As shown in the figure, treatment of B16F10 cells with the far-infrared emitting material provided by the present invention can effectively reduce the melanin content in B16F10 cells by 10% after 24 hours; the melanin content can be reduced by 15% after 48 hours of treatment. It is known from the test that the far-infrared emitting substance provided by the present invention can actually reduce the content of melanin in the cells.

Please refer to the third figure (a)(b), which discloses a histogram of the effect of the far infrared ray releasing substance provided by the present invention on the growth of B16F10 cells in vitro. This test also used B16F10 melanoma cells as test materials, and cultured in a cell culture tray containing 10 ⁴ B16F10 melanoma cells for 16 hours. The cell culture plates were then placed on a 100 gram far infrared ray release material (experimental group) and 100 gram of milk powder (control group) for 24 and 48 hours, respectively. The treated B16F10 melanoma cells were tested for proliferation in vitro by MTT (3,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay. As shown in the figure, treatment of B16F10 cells with the far-infrared emitting material provided by the present invention for 24 hours and 48 hours all had an effect of inhibiting the proliferation of B16F10 cells.

Please refer to the fourth diagram (a)(b), which discloses a histogram of the effect of the far infrared ray releasing substance provided by the present invention on B16F10 cell tyrosinase activity. In this test, B16F10 melanoma cells were also used as test materials, and 6-well cell culture plates containing 10 ⁴ B16F10 melanoma cells per well were cultured for 16 hours. The cell culture plates were then placed on a 100 gram far infrared ray release material (experimental group) and 100 gram of milk powder (control group) for 24 hours. The treated B16F10 melanoma cells were detached from the cell culture dish by trypsin and the treated cells were collected, and then the tyramine in the cells was detected by an enzyme-linked immunosorbent assay (ELISA) assay. Acidase activity. As shown in the figure, the activity of tyrosinase is represented by the absorbance at wavelengths of 650 nm and 370 nm. Treatment of B16F10 cells with the far-infrared emitting material provided by the present invention for 24 hours does inhibit the inhibition of tyrosine in B16F10 cells. The effect of enzyme activity. Because tyrosinase is an important enzyme for the synthesis of melanin precursors, if the enzyme is inhibited, the formation of melanin will be significantly inhibited.

The source of the far-infrared emitting substance used in the invention is a natural mineral component, and not only the piezoelectric negative ions are emitted by the instrument, but also the free radiation is not detected. At present, free radiation is still generally considered to have the risk of causing mutations in the human body and causing cancer. Many far-infrared products in order to increase the emission coefficient of far-infrared rays in the product, adding excessive rare elements, so that the user is exposed to excessive free radiation without Know yourself. The present invention not only has a high far-infrared radiation coefficient, but also has no doubt about free radiation. Therefore, the application products of the present invention, especially those related to the human body or related to the moisture intake of the human body, are very healthy and safe.

However, the above description is only the preferred embodiment of the present invention, and the scope of the present invention is not limited thereto, and the equivalent structural changes of the present specification and the illustrated contents are all included in the same. Within the scope of the invention, it is given to Chen Ming.

10. . . Far infrared ray releasing substance

20. . . Substrate

1 is a schematic view of a preferred embodiment of the far-infrared substrate of the present invention; and second diagram (a) (b): a histogram of the influence of the far-infrared emitting substance of the present invention on the melanin content in B16F10 cells; Figure (a) (b): a histogram of the effect of the far-infrared emitting substance of the present invention on the growth of B16F10 cells in vitro; and the fourth figure (a) (b): the far-infrared emitting substance of the present invention against B16F10 cell tyramine A histogram of the effects of acidase activity.

Claims (16)

A far-infrared emitting material comprising 60-95% of alumina and having a far-infrared light emitted at a wavelength of 4 to 16 μm having a radioactivity of 0.9 or more is used for whitening. A whitening method comprising adding a far-infrared emitting substance to a cream, the far-infrared emitting substance comprising 60-95% of alumina and the far-infrared rays released by the far-infrared emitting substance having a radiation coefficient at a wavelength of 4 to 16 μm Above 0.9. The method of claim 2, wherein the cream further comprises other active substances, adjuvants and additives. The method of claim 2, wherein the cream is a cosmetic product. The method of claim 4, wherein the cosmetic preparation further comprises at least one selected from the group consisting of oils, fats, waxes, hydrocarbons, fatty acids, sterols, hormones, vitamins, fatty acid esters, humectants, surfactants. Cosmetic raw materials for pigments, viscosity improvers, film formers, ultraviolet absorbers, antifungals, anti-inflammatory agents, antiperspirants, preservatives and fragrances. The method of claim 2, wherein the cream is an industrial product selected from the group consisting of paints, coatings, lubricants, films, gels, paper sizing agents, latex, building or road building materials. One of inks, dyes, waxes and polishes. The method of claim 2, wherein the far-infrared emitting material further comprises 1-20% of iron oxide. The method of claim 2, wherein the far infrared ray The release material further contains 1-10% magnesium oxide. The method of claim 2, wherein the far-infrared emitting material further comprises 1-30% of calcium carbonate. A composition for whitening, comprising: a far-infrared emitting substance whose main component is an oxidized mineral and the far-infrared rays emitted therefrom have an emission coefficient of 0.9 or more at a wavelength of 4 to 16 μm, and the composition transmits the far infrared rays. The far-infrared rays released by the released material achieve the purpose of whitening, wherein the oxidized mineral comprises 60-95% of alumina, 1-20% of iron oxide, 1-10% of magnesium oxide and 1-30% of calcium carbonate. The composition described in claim 10 further contains other active substances, adjuvants and additives. The composition of claim 10, wherein the composition is an emulsion, a cream, a gel, a solution, a colloidal dispersion, a suspension, an ointment, a lotion, a cream, a foam, a foamed latex, and a coagulum. At least one of the glues. The composition of claim 10, wherein the composition is a cosmetic composition. The composition of claim 13, wherein the cosmetic composition further comprises at least one selected from the group consisting of oils, fats, waxes, hydrocarbons, fatty acids, sterols, hormones, vitamins, fatty acid esters, humectants, interfaces. Cosmetic raw materials for active agents, pigments, viscosity improvers, film formers, ultraviolet absorbers, antifungals, anti-inflammatory agents, antiperspirants, preservatives and fragrances. The composition of claim 10, wherein the composition A pharmaceutical composition. The composition of claim 15 wherein the pharmaceutical composition further comprises a pharmaceutically acceptable carrier.